Table 2.
Clinical characteristics of patients with COVID-19.
| Patients (n = 24) | |
| Signs and symptoms | |
| Fever | 19(79.17%) |
| Dry cough | 6(25%) |
| Fatigue | 6(25%) |
| Dizziness | 4(16.67%) |
| Lose appetite | 2(8.33%) |
| Muscle ache | 2(8.33%) |
| Headache | 4(16.67%) |
| Shortness of breath | 2(8.33%) |
| Laboratory test | |
| Leucocytes (×109 per L; normal range: 3.5–10) | |
| Normal range | 19(79.17%) |
| Decreased | 5(20.83%) |
| Lymphocytes (×109 per L; normal range: 1.1–3.2) | |
| Normal range | 22(91.67%) |
| Decreased | 2(8.33%) |
| Platelets (×109 per L; normal range: 100–300) | |
| Normal range | 24(100%) |
| Procalcitonin (ng/mL; normal range: 0–0.5) | |
| Normal range | 22(91.67%) |
| Decreased | 2(8.33%) |
| Erythrocyte sedimentation rate (mm/h, normal range: 0–15) | |
| Increased | 6(25%) |
| Normal range | 18(75%) |
| C-reactive protein (mg/L; normal range: 0–5) | |
| Increased | 12(50%) |
| Normal range | 12(50%) |
| CT findings | |
| No pneumonia | 6(25%) |
| Pneumonia | 18(75%) |
| Symptoms and pneumonia | |
| Neither symptoms nor pneumonia | 3(12.5%) |
| Both symptoms and pneumonia | 18(75%) |
| Symptoms but no pneumonia | 3(12.5%) |
| No symptoms but pneumonia | 0 |
| Type | |
| Asymptomatic infection | 3(12.5%) |
| Mild | 3(12.5%) |
| Moderate | 18(75%) |
| Severe | 0 |